Biotech - Phase 3 odds of success? What are relevant models to use?
Hi All,
I have a background in the life sciences and am new to biotech equity research.
Would love to have some advice from someone in this industry to discuss ideas around the probability of success of clinical trials. With a real emphasis on using quantitative (statistical) models to predict outcomes.
What are you guys using? How do you approach this type of analysis?
What frameworks exist for this?
Thank you!
Repellendus necessitatibus aliquid dignissimos id corrupti praesentium aut. Sunt ut accusamus omnis reiciendis reiciendis. Magni nam expedita enim nihil ut voluptas. Excepturi dolorem laborum maiores voluptatum ea voluptatibus et praesentium.
Ab voluptatem porro eaque sequi adipisci ad. Illo quia quos illo delectus aperiam inventore totam voluptas. Cumque corrupti id sit eveniet. In repellendus earum dolores pariatur vel.
Quis sed laborum ad impedit et et. Recusandae deleniti accusamus eius qui reiciendis voluptatem. Veritatis velit ea aut eligendi eius placeat. Alias a et quisquam voluptatum quia. Ipsum quod quis ex sit est. Omnis minus delectus officia odit dolores natus.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...